Notícias · Recifes

Genetic information helps predict the onset and progression of glaucoma

Glaucoma is the leading cause of irreversible visual impairment worldwide. Because the disease often progresses without symptoms for years, many patients are diagnosed only after permanent damage to the optic nerve has already occurred. Earlier detection through targeted screenin

Admin Recifes 15/07/2026 2

Repurposed cancer drug rapidly eased rare autoimmune neuropathy in two patients

An interdisciplinary team at Jena University Hospital achieved a surprisingly rapid and significant improvement in two patients with an autoimmune peripheral nervous system disorder. The team administered teclistamab, a drug originally developed for multiple myeloma, and reported

Admin Recifes 15/07/2026 2

Editing AI mistakes can cost doctors time when writing to patients

Errors and irrelevant details mean physicians may spend more time editing AI-drafted responses than it would take to write them, a large study of an online patient portal shows. Artificial intelligence is spreading rapidly in health care, with the goal of streamlining critical bu

Admin Recifes 15/07/2026 2

AI test predicts breast cancer recurrence in hours, not weeks, across 3,500 patients

In recent years, notable advances have been made in diagnosing and treating breast cancer. However, its recurrence continues to plague thousands, deepening the need to find ways to better predict the likelihood of its return.

Admin Recifes 15/07/2026 2

Biomarker-guided care to improve antidepressant response rates and reduce trial-and-error

For millions of people living with depression, finding an effective treatment can feel like a long and uncertain journey. Patients often spend months trying different medications, enduring side effects and persistent symptoms while waiting to discover whether a prescription will

Admin Recifes 15/07/2026 2

Researchers discover treatable cause of severe anemia associated with a cancer therapy

Researchers at the Mount Sinai Tisch Cancer Center have identified a previously underrecognized folate deficiency that may cause severe anemia in some patients receiving PARP inhibitors, a widely used class of targeted cancer therapies. Their findings, published in the latest iss

Admin Recifes 15/07/2026 2

Brain tumor vaccine links mutation targeting to eight-year survival gains

A novel vaccination strategy against certain malignant brain tumors could fundamentally improve treatment for patients. Researchers from the German Cancer Research Center (DKFZ), Mannheim University Medical Center, Heidelberg University Hospital and numerous partner institutions

Admin Recifes 15/07/2026 2

Blood test may help identify which colorectal cancer patients most likely to benefit from

A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at the ESMO Gastrointestinal Cancers Congress 2026.

Admin Recifes 15/07/2026 1

Longer persistence seen with Upadacitinib versus tumor necrosis factor inhibitors in rheum

Patients with rheumatoid arthritis (RA) have longer persistence with upadacitinib than tumor necrosis factor inhibitors (TNFi), according to a study published online June 23 in Rheumatology.

Admin Recifes 15/07/2026 2

Pembrolizumab-belzutifan tied to improved disease-free survival in renal cell carcinoma

For patients with clear-cell renal cell carcinoma, pembrolizumab-belzutifan yields significantly higher disease-free survival, according to a study published in the July 2 issue of the New England Journal of Medicine.

Admin Recifes 15/07/2026 2

New study reveals how same day care can ease NHS emergency pressures

A new study led by the University of Sheffield and published in BMJ Open has found that up to one-third of A&E attendances and two-fifths of acute admissions could potentially be managed through same-day emergency care (SDEC) and community settings—keeping patients safe and treat

Admin Recifes 15/07/2026 2

1 in 5 relatives of breast and ovarian cancer patients in Estonia carry dangerous cancer-l

In 2013, Angelina Jolie inspired a wave of testing for pathogenic variants of the gene BRCA1 by announcing that she carried a variant that left her at such high risk of breast cancer that she chose a preventive mastectomy. Many people with similar gene variants won't need risk-re

Admin Recifes 15/07/2026 2

Acompanhe as Notícias da Recifes